Stay updated with breaking news from Robotics Daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bellevue Group AG trimmed its holdings in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT – Free Report) by 0.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 885,346 shares of the company’s stock after selling 2,950 shares during the period. Bellevue Group AG’s holdings […]
PROCEPT BioRobotics Co. (NASDAQ:PRCT – Get Free Report) has been given a consensus rating of “Buy” by the seven analysts that are presently covering the company, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have updated their coverage on the stock in […]
Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT – Get Free Report) have earned a consensus rating of “Buy” from the seven research firms that are presently covering the company, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a buy recommendation. The average 12-month price target among brokerages that have issued a report on […]
PROCEPT BioRobotics (NASDAQ:PRCT – Get Free Report) and Hypertension Diagnostics (OTCMKTS:HDII – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, earnings, dividends and profitability. Volatility & Risk PROCEPT BioRobotics has a beta […]
Lisanti Capital Growth LLC acquired a new position in PROCEPT BioRobotics Co. (NASDAQ:PRCT – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 121,690 shares of the company’s stock, valued at approximately $5,100,000. PROCEPT BioRobotics makes up 1.2% of Lisanti Capital Growth LLC’s […]